Gut microbiota

Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection

by Heather Eberly
14 de June de 202114 de June de 2021

The gut microbiome alters immunophenotype and survival from sepsis

by Heather Eberly
14 de June de 202114 de June de 2021

Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production

by Heather Eberly
14 de June de 202114 de June de 2021

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

by Heather Eberly
14 de June de 202114 de June de 2021

Viral Infections, the Microbiome, and Probiotics

by Heather Eberly
14 de June de 202114 de June de 2021

Gut microbiota in human metabolic health and disease

by Heather Eberly
14 de June de 2021

The role of the gut microbiome in the healthy adult status

by Heather Eberly
14 de June de 2021

How human microbiome talks to health and disease

by Heather Eberly
14 de June de 202114 de June de 2021

The Microbiota in Immunity and Inflammation

by Heather Eberly
14 de June de 2021

Host-microbiota interactions in immune-mediated diseases

by Heather Eberly
14 de June de 202114 de June de 2021

Kaneka Americas Holding, Inc.
Probiotics Division
7979 Gateway Boulevard, Newark (CA)
94560 United States

2024 © Kaneka Americas Holding, Inc. All Rights Reserved.

Enter your information to download exclusive content. Thank you!

Enter your information to download exclusive content. Thank you!
Email*
First name*
Last name*
Company*
Country*
Department*
Consent*
- Accept Privacy policy
Name
This field is for validation purposes and should be left unchanged.